Pulmonary retransplantation:: Predictors of graft function and survival in 230 patients

被引:89
作者
Novick, RJ [1 ]
Stitt, LW
Al-Kattan, K
Klepetko, W
Schäfers, HJ
Duchatelle, JP
Khaghani, A
Hardesty, RL
Patterson, GA
Yacoub, MH
机构
[1] London Hlth Sci Ctr, Dept Surg, POB 5339, London, ON N6A 5A5, Canada
[2] London Hlth Sci Ctr, Dept Epidemiol & Biostat, London, ON N6A 5A5, Canada
[3] Robarts Res Inst, London, ON N6A 5C1, Canada
[4] Univ Western Ontario, London, ON, Canada
[5] Alfred Hosp, Melbourne, Vic, Australia
[6] Ctr Hlth Sci, Winnipeg, MB, Canada
[7] Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada
[8] London Hlth Sci Ctr, London, England
[9] Toronto Hosp, Toronto, ON M5T 2S8, Canada
[10] Vancouver Gen Hosp, Vancouver, BC, Canada
[11] Allegemeine Krankenhaus, Vienna, Austria
[12] Hop Erasme, Brussels, Belgium
[13] Rigshosp, DK-2100 Copenhagen, Denmark
[14] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England
[15] Harefield Hosp, Harefield UB9 6JH, Middx, England
[16] Papworth Hosp, Cambridge CB3 8RE, England
[17] Wythenshawe Hosp, Manchester M23 9LT, Lancs, England
[18] Univ Helsinki, Cent Hosp, Helsinki, Finland
[19] Hop Beaujon, Clichy, France
[20] CHU Grenoble, F-38043 Grenoble, France
[21] Hop Enfants La Timone, Marseille, France
[22] Hop Marie Lannelongue, Paris, France
[23] Hop Xavier Arnozan, Pessac, France
[24] Ctr Medicochirurg Foch, Suresnes, France
[25] Hannover Med Sch, Hannover, Germany
[26] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany
[27] Acad Ziekenhuis, Groningen, Netherlands
[28] Osped San Giovanni Battista Torino, Turin, Italy
[29] Univ Oslo, Rikshosp, N-0027 Oslo, Norway
[30] Univ Spital Zurich, Zurich, Switzerland
[31] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[32] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[33] Loyola Univ Med Ctr, Maywood, IL 60153 USA
[34] Univ Iowa Hosp, Iowa City, IA USA
[35] Univ Kentucky, Albert B Chandler Med Ctr, Lexington, KY 40536 USA
[36] Alton Ochsner Med Fdn & Ochsner Clin, New Orleans, LA 70121 USA
[37] Brigham & Womens Hosp, Boston, MA 02115 USA
[38] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[39] Univ Minnesota, Ctr Hlth, Minneapolis, MN 55455 USA
[40] St Louis Childrens Hosp, St Louis, MO 63178 USA
[41] Washington Univ, Barnes Jewish Hosp, St Louis, MO USA
[42] Duke Univ, Med Ctr, Durham, NC USA
[43] Univ N Carolina, Med Ctr, Chapel Hill, NC USA
[44] Hosp Univ Penn, Philadelphia, PA 19104 USA
[45] Univ Pittsburgh, Presbyterian Hosp, Pittsburgh, PA 15213 USA
[46] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[47] Baylor Methodist Hosp, Houston, TX USA
[48] Univ Texas, Med Ctr, San Antonio, TX 78285 USA
[49] Univ Virginia, Hlth Sci Ctr, Charlottesville, VA USA
[50] Univ Washington, Sch Med, Seattle, WA USA
关键词
D O I
10.1016/S0003-4975(97)01191-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Despite improving results in lung transplantation, a significant number of grafts fail early or late postoperatively. The pulmonary retransplant registry was founded in 1991 to determine the predictors of outcome after retransplantation. We hypothesized that ambulatory status of the recipient and center retransplant volume, which had been previously shown to predict survival after retransplantation, would also be associated with improved graft function postoperatively. Methods. Two hundred thirty patients underwent retransplantation in 47 centers from 1985 to 1996. Logistic regression methods were used to determine variables associated with, and predictive of, survival and lung function after retransplantation. Results. Kaplan-Meier survival was 47% +/- 3%, 40% +/- 3%, and 33% +/- 4% at 1, 2, and 3 years, respectively. On multivariable analysis, the predictors of survival included ambulatory status or lack of ventilator support preoperatively (p = 0.005; odds ratio, 1.62; 95% confidence interval, 1.15 to 2.27), followed by retransplantation after 1991 (p = 0.048; odds ratio, 1.41; 95% confidence interval, 1.003 to 1.99). Ambulatory, nonventilated patients undergoing retransplantation after 1991 had a 1-year survival of 64% +/- 5% versus 33% +/- 4% for nonambulatory, ventilated recipients. Eighty-one percent, 70%, 62%, and 56% of survivors were free of bronchiolitis obliterans syndrome at 1, 2, 3, and 4 years after retransplantation, respectively. Factors associated with freedom from stage 3 (severe) bronchiolitis obliterans syndrome at 2 years after retransplantation included an interval between transplants greater than 2 years (p = 0.01), the lack of ventilatory support before retransplantation (p = 0.03), increasing retransplant experience within each center (fifth and higher retransplant patient, p = 0.04), and total center volume of five or more retransplant operations (P = 0.05). Conclusions. Nonambulatory, ventilated patients should not be considered for retransplantation with the same priority as other candidates. The best intermediate-term functional results occurred in more experienced centers, in nonventilated patients, and in patients undergoing retransplantation more than 2 years after their first transplant. In view of the scarcity of lung donors, patient selection for retransplantation should remain strict and should be guided by the outcome data reviewed in this article. (C) 1998 by The Society of Thoracic Surgeons.
引用
收藏
页码:227 / 234
页数:8
相关论文
共 23 条
  • [1] RETRANSPLANTATION IN HEART-LUNG RECIPIENTS WITH OBLITERATIVE BRONCHIOLITIS
    ADAMS, DH
    COCHRANE, AD
    KHAGHANI, A
    SMITH, JD
    YACOUB, MH
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 107 (02) : 450 - 459
  • [2] COLLINS EG, 1993, HEART LUNG, V22, P206
  • [3] COOPER JD, 1993, J HEART LUNG TRANSPL, V12, P713
  • [4] RESULTS OF SINGLE AND BILATERAL LUNG TRANSPLANTATION IN 131 CONSECUTIVE RECIPIENTS
    COOPER, JD
    PATTERSON, A
    TRULOCK, EP
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 107 (02) : 460 - 471
  • [5] IMPROVED AIRWAY HEALING AFTER LUNG TRANSPLANTATION - AN ANALYSIS OF 348 BRONCHIAL ANASTOMOSES
    DATE, H
    TRULOCK, EP
    ARCIDI, JM
    SUNDARESAN, S
    COOPER, JD
    PATTERSON, GA
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (05) : 1424 - 1433
  • [6] IMPROVED RESULTS OF LUNG TRANSPLANTATION FOR PATIENTS WITH CYSTIC-FIBROSIS
    EGAN, TM
    DETTERBECK, FC
    MILL, MR
    PARADOWSKI, LJ
    LACKNER, RP
    OGDEN, WD
    YANKASKAS, JR
    WESTERMAN, JH
    THOMPSON, JT
    WEINER, MA
    CAIRNS, EL
    WILCOX, BR
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (02) : 224 - 235
  • [7] FOURNIER M, 1993, EUR RESPIR J, V6, P1202
  • [8] HARRIS EK, 1991, SURVIVORSHIP ANAL CL, P12
  • [9] Hosenpud JD, 1996, J HEART LUNG TRANSPL, V15, P655
  • [10] HOSMER DW, 1989, APPL LOGISTIC REGRES, P1